ClassID:

21061

A61K39/0006 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies; Vertebrate antigens Contraceptive vaccins; Vaccines against sex hormones

Recent Application in this class:
#1
20260137764
2026-05-21

METHOD FOR CASTRATION OF ANIMALS

#2
20250049899
2025-02-13

IMMUNOGENIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF

#3
20240424073
2024-12-26

CONTRACEPTIVE VACCINE BASED ON THE SPERM-ASSOCIATED PROTEIN CATSPER

#4
20240299511
2024-09-12

AN IMMUNOGEN

#5
20230218729
2023-07-13

RECOMBINANT PROTEIN FOR NEUTERING OR SPAYING ANIMAL, AND VACCINE COMPOSITION COMPRISING SAME

#6
20230173044
2023-06-08

RECOMBINANT PROTEIN FOR REMOVING BOAR TAINT AND VACCINE COMPOSITION COMPRISING THE SAME

#7
20230136261
2023-05-04

METHODS AND COMPOSITIONS FOR VIRAL VECTORED GnRH VACCINES TO CONTROL REPRODUCTION AND BREEDING BEHAVIOR IN MAMMALS

#8
20230027709
2023-01-26

COMPOSITIONS AND METHODS FOR REGULATING SAS1R

#9
20220305131
2022-09-29

MODIFIED VIRUS-LIKE PARTICLES OF CMV

#10
20220152166
2022-05-19

A CONTRACEPTIVE VACCINE BASED ON THE SPERM-ASSOCIATED PROTEIN CATSPER

#11
20220016225
2022-01-20

VACCINE COMPOSITIONS AND ADJUVANT

#12
20200155699
2020-05-21

Modified virus-like particles of CMV

#13
20200069781
2020-03-05

IMMUNOGENIC LHRH COMPOSITION AND USE THEREOF IN PIGS

#14
20190201511
2019-07-04

Placental Based Contraceptive Vaccine

#15
20180177869
2018-06-28

Microfluidized fragments as an adjuvant and carrier for mucosal vaccine delivery

#16
20180066052
2018-03-08

COMPOSITIONS AND METHODS FOR REGULATING SAS1R

#17
20170312371
2017-11-02

Modified virus-like particles of CMV

#18
20170216418
2017-08-03

IMMUNOGENIC LHRH COMPOSITION AND USE THEREOF IN PIGS

#19
20160355593
2016-12-08

ANTIBODY VACCINE CONJUGATES AND USES THEREFOR

#20
20150190491
2015-07-09

Pharmaceutical composition using gonadotropin-releasing hormone (GNRH) combined variants as immunogen

#21
20150093406
2015-04-02

Modified coiled coil type proteins having improved properties

#22
20150044241
2015-02-12

Contraceptive vaccines for mammals

#23
20120328639
2012-12-27

Immunogenic LHRH compositions and methods relating thereto

#24
20120252031
2012-10-04

Compositions and methods for regulating SAS1R

#25
20120251566
2012-10-04

Saponin adjuvant compositions and methods relating thereto

#26
20120164165
2012-06-28

Zona pellucida binding peptides for species specific immunocontraception of animals

#27
20120093846
2012-04-19

Protein for the immunocastration for mammals

#28
20110311565
2011-12-22

Phage constructs, sequences and antigenic compositions for immunocontraception of animals

#29
20110293647
2011-12-01

IMMUNOGENIC LHRH COMPOSITIONS AND METHODS RELATING THERETO

#30
20110250196
2011-10-13

Pharmaceutical composition using gonadotropin-releasing hormone (GNRH) combined variants as immunogen

#31
20110165189
2011-07-07

Rabies virus-based recombinant immunocontraceptive compositions and methods of use

#32
20110044989
2011-02-24

Methods of identifying peptides and compositions that bind to oocytes in a species-specific manner

#33
20110020350
2011-01-27

Contraceptives Based on SP22 and SP22 Antibodies

#34
20100329987
2010-12-30

Uses of Sperm Membrane Protein OBF

#35
20100203136
2010-08-12

METHOD FOR DELIVERING A HUMAN CHORIONIC GONADOTROPIN (Hcg) VACCINE FOR LONG-ACTING ANTIBODY PROTECTION

#36
20100183641
2010-07-22

SPERM LIGANDS AND METHODS OF USE

#37
20100183617
2010-07-22

COMPOSITIONS AND METHODS FOR REGULATING SAS1R

#38
20100092500
2010-04-15

Immunogenic lipopeptides comprising T-helper and B-cell epitopes

#39
20090324622
2009-12-31

ANTIBODY VACCINE CONJUGATES AND USES THEREFOR

#40
20090291098
2009-11-26

Immunogenic LHRH compositions and methods relating thereto

#41
20090280137
2009-11-12

Methods for identifying peptides that bind to intact oocytes

#42
20090226489
2009-09-10

Viral vaccine composition, process and methods of use

#43
20090226484
2009-09-10

Immunogenic LHRH compositions and methods relating thereto

#44
20090105155
2009-04-23

TRUNCATED LHRH FORMULATIONS

#45
20090028886
2009-01-29

Carrier conjugates of gnrh-peptides

#46
20080279812
2008-11-13

Disease Prevention and Vaccination Prior to Thymic Reactivation

#47
20080233181
2008-09-25

NANOPARTICLE ADJUVANTS FOR SUB-UNIT VACCINES

#48
20080233153
2008-09-25

Vaccine compositions and adjuvant

#49
20080193469
2008-08-14

Contraceptives based on SP22 and SP22 antibodies

#50
20080187549
2008-08-07

Polyantigenic-based (multiple antigens) modi or set of methods for developing infertility vaccines

#51
20080152664
2008-06-26

Sperm ligands and methods of use

#52
20080124380
2008-05-29

Contraceptives based on SP22 and SP22 antibodies

#53
20080095738
2008-04-24

VLP-antigen conjugates and their uses as vaccines

#54
20080025982
2008-01-31

Uses of Sperm Membrane Protein Obf

#55
20070184064
2007-08-09

Chimeric peptide immunogens

#56
20070066534
2007-03-22

Immunogenic lipopeptides comprising T-helper and B-cell epitopes

#57
20060121051
2006-06-08

Heat shock fusion-based vaccine system

#58
20060121010
2006-06-08

Chorionic gonadotropin DNA vaccines and methods

#59
20060024290
2006-02-02

Immunogenic LHRH compositions and methods relating thereto

#60
20060013821
2006-01-19

Vaccine compositions and adjuvant

#61
20050191318
2005-09-01

DNA immunocontraceptive vaccines and uses thereof

#62
20050180983
2005-08-18

Antibody vaccine conjugates and uses therefor

#63
20050112721
2005-05-26

Chimeric peptide immunogens

#64
20050106137
2005-05-19

Chimeric peptide immunogens

#65
20050096283
2005-05-05

Methods of inhibiting fertility

#66
20050095258
2005-05-05

Fusion proteins comprising carriers that can induce a dual immune response

#67
20050074460
2005-04-07

Process for preparing conjugate vaccines and the conjugate vaccines

#68
20050069536
2005-03-31

Contraceptives based on SP22 and SP22 antibodies

#69
20050009188
2005-01-13

Animal immunocontraceptives expressed in plants and uses thereof

#70
10769144
2016-01-26

Antibody vaccine conjugates and uses therefor